期刊
ADVANCED SCIENCE
卷 8, 期 3, 页码 -出版社
WILEY
DOI: 10.1002/advs.202001960
关键词
antiglioblastomas; BBB permeability; MMP‐ 2; paclitaxel; peptide‐ drug conjugations
资金
- China Scholarship Council [201606945004]
- National Natural Science Foundation of China [81402050, 81502166, 81672592, 81872061, 81972354]
- Programs of Science and Technology Bureau Foundation of Tianjin Municipality [16JCQNJC13400, 17JCYBJC27100, 19JCZDJC64900(Z)]
- Program of Tianjin Municipal Health Bureau [15KG147]
- New Century Talent Training Project of TMUGH (2016)
- New Century Talent Training Project of TMUGH (2018)
A novel dual-functional nanocomplex drug delivery system, SynB3-PVGLIG-PTX, was developed based on the strategy of peptide-drug conjugates. It exhibited specific inhibition on proliferation, migration, and invasion of GBM cells in vitro through the cleavage of MMP-2 to release PTX.
In order to solve the problems of receptor promiscuity and poor blood-brain barrier (BBB) penetration in the treatment of glioblastomas (GBM), a novel dual-functional nanocomplex drug delivery system is developed based on the strategy of peptide-drug conjugates. In this study, SynB3-PVGLIG-PTX is designed and screened out by matrix metalloproteinase-2 (MMP-2), to which it exhibits the best affinity. The MMP-2-sensitive peptide (PVGLIG) and a cell-penetration peptide (SynB3) are combined to form a dual-functional peptide. Moreover, as a drug-peptide nanocomplex, SynB3-PVGLIG-PTX exhibited a high potential to form an aggregation with good solubility that can release paclitaxel (PTX) through the cleavage of MMP-2. From a functional perspective, it is found that SynB3-PVGLIG-PTX can specifically inhibit the proliferation, migration, and invasion of GBM cells in vitro in the presence of MMP-2, in contrast to that observed in MMP-2 siRNA transfected cells. Further investigation in vivo shows that SynB3-PVGLIG-PTX easily enters the brain of U87MG xenograft nude mice and can generate a better suppressive effect on GBM through a controlled release of PTX from SynB3-PVGLIG-PTX compared with PTX and temozolomide. Thus, it is proposed that SynB3-PVGLIG-PTX can be used as a novel drug-loading delivery system to treat GBM due to its specificity and BBB permeability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据